Clinical Trials List
Protocol NumberCOAV101A12308
2023-01-10 - 2035-06-15
Phase IV
Recruiting2
ICD-10G12.9
Spinal muscular atrophy, unspecified
ICD-9335.10
Spinal muscular atrophy, unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- WEN-CHIN WENG Division of General Internal Medicine
- 陳俊安 Division of General Internal Medicine
- WUH-LIANG HWU Division of General Internal Medicine
- 謝正宜 Division of General Internal Medicine
- 呂立 Division of General Internal Medicine
- NI-CHUNG LEE Division of General Internal Medicine
- WANG-TSO LEE Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
260 participants
